English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1244]
News [2385]
Articles [91]
Editorials [4]
Conferences [117]
elearning [25]
LUME study of nintedanib finds improved PFS, but no overall survival boost
Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
LUME study of nintedanib finds improved PFS, but no overall survival boost ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
12 Oct 2016
Highlights of ESMO 2016
Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016
Significant survival gains for neoadjuvant chemotherapy for high risk soft...
Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy
Significant survival gains for neoadjuvant chemotherapy for high risk soft tissue sarcoma ( Dr Alessandro Gronchi - National Cancer Institute, Milan, Italy )
10 Oct 2016
Dabrafenib shows higher response and lower toxicity in paediatric brain cancer...
Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders...
Dabrafenib shows higher response and lower toxicity in paediatric brain cancer trial ( Dr Mark Kieran - Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, USA )
8 Oct 2016
Screening, surgical cure and new developments: Future smart surgical approaches...
Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan...
Screening, surgical cure and new developments: Future smart surgical approaches for brain mets ( Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy )
6 Oct 2016
NSCLC biology and new therapies: Reversing resistance
Prof Michael Seckl - Imperial College London, London, UK
NSCLC biology and new therapies: Reversing resistance ( Prof Michael Seckl - Imperial College London, London, UK )
5 Oct 2016
Screening, surgical cure and new developments: How to avoid false positives in...
Dr Claudia Henschke - Mount Sinai Hospital, New York, USA
Screening, surgical cure and new developments: How to avoid false positives in lung cancer screening ( Dr Claudia Henschke - Mount Sinai Hospital, New York, USA )
5 Oct 2016
Developments in checkpoint immunotherapy
Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK
Developments in checkpoint immunotherapy ( Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK )
22 Sep 2016
Very late relapse in Hodgkins lymphoma
Dr Paul Bröckelmann - University Hospital of Cologne, Cologne, Germany
Very late relapse in Hodgkins lymphoma ( Dr Paul Bröckelmann - University Hospital of Cologne, Cologne, Germany )
6 Jul 2016
Modelling ponatinib resistance in BCR-ABL1 cell lines
Dr Liu Lu - South Australian Health and Medical Research Institute, Adelaide...
Modelling ponatinib resistance in BCR-ABL1  cell lines ( Dr Liu Lu - South Australian Health and Medical Research Institute, Adelaide, Australia )
1 Jul 2016
Editor's Choice for June 2016
Prof Gordon McVie - ecancer Editor in Chief
Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )
29 Jun 2016
Results from the EURO-SKI cessation trial of TKIs in CML
Dr Johan Richter - Lund University, Lund, Sweden
Results from the EURO-SKI cessation trial of TKIs in CML ( Dr Johan Richter - Lund University, Lund, Sweden )
23 Jun 2016
<1...7576777879...104>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top